Related Experiment Video
Updated: Feb 17, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Oral anticoagulant therapy is increasingly prescribed, but practical guidance on initiation, monitoring, and management is often lacking. This article focuses on these essential, real-world aspects of anticoagulant use.
Area of Science:
- Pharmacology
- Internal Medicine
- Clinical Therapeutics
Background:
- Oral anticoagulant prescriptions have risen due to clarified indications from clinical trials.
- Practical aspects of oral anticoagulant therapy are often not sufficiently addressed.
- Information on the practical management of oral anticoagulants can be difficult to locate.
Purpose of the Study:
- To address practical aspects of oral anticoagulant therapy.
- To provide guidance on initiation, monitoring, dose adjustment, and management.
- To supplement existing comprehensive reviews with essential clinical details.
Main Methods:
- This article emphasizes practical aspects rather than providing a comprehensive review.
- Focuses on real-world clinical application and management strategies.
- Synthesizes information on key therapeutic considerations.
Main Results:
- Highlights common challenges in oral anticoagulant therapy.
- Provides actionable insights for clinicians.
- Addresses practical issues not typically covered in depth.
Conclusions:
- Practical management is crucial for effective oral anticoagulant therapy.
- Clinicians require accessible guidance on day-to-day therapeutic decisions.
- This article serves as a resource for optimizing patient care with oral anticoagulants.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care
Venous Thrombosis IV: Nursing Management

